Chinese firm CNBG says Covid-19 vaccine candidate shows prom
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
Get authentic, real-time news that helps you fight COVID-19 better.
Install PlexusMD App for doctors. It's free.
A Covid-19 vaccine candidate developed by a Beijing unit of China National Biotec Group (CNBG) has shown positive results in early human trials, the company said on 28 June.

• According to the company, all 1,120 volunteers in the phase-1 and phase-2 clinical trials produced high-titer antibodies against Covid-19 after accepting two doses of the vaccine, the Global Times reported.

• The trials were designed as randomized, double-blind and placebo-controlled studies.

• This is not the first Covid-19 vaccine candidate from CNBG, which is affiliated to the state-owned China National Pharmaceutical Group (Sinopharm).

• In the middle of this month, another institute under CNBG in Wuhan announced the results of phase-1 and Phase-2 clinical trials of an inactivated Covid-19 vaccine candidate it developed.

• These trials, which started on April 12, also involved 1,120 volunteers and the results revealed a good safety record, with no cases of severe adverse effects found in the clinical trials.

Source: https://health.economictimes.indiatimes.com/news/industry/covid-19-vaccine-from-china-shows-promise-in-human-trials/76681221
Dr. T●●●●z H●●●●●●i and 3 others like this2 shares
Like
Comment
Share